These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27898751)

  • 21. Effectiveness of the risk of malignancy index and the risk of ovarian malignancy algorithm in a cohort of women with ovarian cancer: does histotype and stage matter?
    Lennox GK; Eiriksson LR; Reade CJ; Leung F; Mojtahedi G; Atenafu EG; Ferguson SE; Murphy J; Diamandis EP; Kulasingam V; Bernardini MQ
    Int J Gynecol Cancer; 2015 Jun; 25(5):809-14. PubMed ID: 25855958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison between an ultrasound based prediction model (LR2) and the risk of ovarian malignancy algorithm (ROMA) to assess the risk of malignancy in women with an adnexal mass.
    Kaijser J; Van Gorp T; Van Hoorde K; Van Holsbeke C; Sayasneh A; Vergote I; Bourne T; Timmerman D; Van Calster B
    Gynecol Oncol; 2013 May; 129(2):377-83. PubMed ID: 23360924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are serum HE4 or ROMA scores useful to experienced examiners for improving characterization of adnexal masses after transvaginal ultrasonography?
    Kaijser J; Van Gorp T; Smet ME; Van Holsbeke C; Sayasneh A; Epstein E; Bourne T; Vergote I; Van Calster B; Timmerman D
    Ultrasound Obstet Gynecol; 2014 Jan; 43(1):89-97. PubMed ID: 23828371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of malignancy index validity assessment in premenopausal and postmenopausal women with adnexal tumors.
    Terzic M; Dotlic J; Likic I; Brndusic N; Pilic I; Ladjevic N; Maricic S; Arsenovic N; Maricic Z
    Taiwan J Obstet Gynecol; 2013 Jun; 52(2):253-7. PubMed ID: 23915860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of risk of malignancy indices; RMI 1-4 in borderline ovarian tumor.
    Yenen MC; Alanbay I; Aktürk E; Ercan CM; Coksuer H; Karaşahin E; Ozan H; Dede M
    Eur J Gynaecol Oncol; 2012; 33(2):168-73. PubMed ID: 22611957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian fibroma/fibrothecoma: retrospective cohort study shows limited value of risk of malignancy index score.
    Numanoglu C; Kuru O; Sakinci M; Akbayır O; Ulker V
    Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):287-92. PubMed ID: 23611791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MMP3 in Comparison to CA 125, HE4 and the ROMA Algorithm in Differentiation of Ovarian Tumors.
    Cymbaluk-Ploska A; Chudecka-Glaz A; Surowiec A; Pius-Sadowska E; Machalinski B; Menkiszak J
    Asian Pac J Cancer Prev; 2016; 17(5):2597-603. PubMed ID: 27268637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative HE4, CA125 and ROMA in the differential diagnosis of benign and malignant adnexal masses.
    Terlikowska KM; Dobrzycka B; Witkowska AM; Mackowiak-Matejczyk B; Sledziewski TK; Kinalski M; Terlikowski SJ
    J Ovarian Res; 2016 Jul; 9(1):43. PubMed ID: 27436085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of preoperative ROMA scores with clinical stage in epithelial ovarian cancer patients.
    Li QL; Wang CJ; Qi P; Zhang YX
    Clin Transl Oncol; 2017 Oct; 19(10):1260-1267. PubMed ID: 28444641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic accuracy and cost-effectiveness of different strategies to triage women with adnexal masses: a prospective study.
    Piovano E; Cavallero C; Fuso L; Viora E; Ferrero A; Gregori G; Grillo C; Macchi C; Mengozzi G; Mitidieri M; Pagano E; Zola P
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):395-403. PubMed ID: 27706929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-operative evaluation of ovarian mass: risk of malignancy index.
    Asif N; Sattar A; Dawood MM; Rafi T; Aamir M; Anwar M
    J Coll Physicians Surg Pak; 2004 Mar; 14(3):128-31. PubMed ID: 15228841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Copenhagen Index versus ROMA in preoperative ovarian malignancy risk stratification: Result from the first Vietnamese prospective cohort study.
    Tran DT; Vo VK; Le MT; Chuang L; Nguyen VQH
    Gynecol Oncol; 2021 Jul; 162(1):113-119. PubMed ID: 33994145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the Copenhagen Index versus ROMA for the preoperative assessment of women with ovarian tumors.
    Minar L; Felsinger M; Cermakova Z; Zlamal F; Bienertova-Vasku J
    Int J Gynaecol Obstet; 2018 Feb; 140(2):241-246. PubMed ID: 29086914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of risk of malignancy indices in evaluating ovarian masses in a Southeast Asian population.
    Ong C; Biswas A; Choolani M; Low JJ
    Singapore Med J; 2013 Mar; 54(3):136-9. PubMed ID: 23546025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of four malignancy risk indices in the preoperative evaluation of patients with pelvic masses.
    Yamamoto Y; Yamada R; Oguri H; Maeda N; Fukaya T
    Eur J Obstet Gynecol Reprod Biol; 2009 Jun; 144(2):163-7. PubMed ID: 19327881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of Diagnostic Values among CA-125, RMI, HE4, and ROMA for Cancer Prediction in Women with Nonfunctional Ovarian Cysts.
    Oranratanaphan S; Wanishpongpan S; Termrungruanglert W; Triratanachat S
    Obstet Gynecol Int; 2018; 2018():7821574. PubMed ID: 30402106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of ultrasound score, CA125, menopausal status, and risk of malignancy index in differentiating between benign and borderline or malignant ovarian tumors.
    Leelahakorn S; Tangjitgamol S; Manusirivithaya S; Thongsuksai P; Jaroenchainon P; Jivangkul C
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S22-30. PubMed ID: 17718292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic Value of Risk of Malignancy Algorithm (ROMA) in Adnexal Masses.
    Kumar V; Rajan S; Gupta S; Akhtar N; Sharma S; Sinha P; Misra S; Chaturvedi A
    J Obstet Gynaecol India; 2020 Jun; 70(3):214-219. PubMed ID: 32476768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Approaches to the detection of ovarian cancer.
    Høgdall E
    Scand J Clin Lab Invest Suppl; 2016; 245():S49-53. PubMed ID: 27435369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of HE 4, CA 125, ROMA score and ultrasound score in the differential diagnosis of ovarian masses.
    Aslan K; Onan MA; Yilmaz C; Bukan N; Erdem M
    J Gynecol Obstet Hum Reprod; 2020 May; 49(5):101713. PubMed ID: 32084612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.